TY - JOUR AU - Kaatsch, P. PY - 2010 DA - 2010// TI - Epidemiology of childhood cancer JO - Cancer Treat Rev VL - 36 UR - https://doi.org/10.1016/j.ctrv.2010.02.003 DO - 10.1016/j.ctrv.2010.02.003 ID - Kaatsch2010 ER - TY - JOUR AU - Terracini, B. PY - 2011 DA - 2011// TI - Epidemiology of childhood cancer JO - Environ Health VL - 10 Suppl 1 UR - https://doi.org/10.1186/1476-069X-10-S1-S8 DO - 10.1186/1476-069X-10-S1-S8 ID - Terracini2011 ER - TY - JOUR AU - Liu, J. AU - Yang, C. AU - Simpson, C. AU - Deryckere, D. AU - Van Deusen, A. AU - Miley, M. J. AU - Kireev, D. AU - Norris-Drouin, J. AU - Sather, S. AU - Hunter, D. PY - 2012 DA - 2012// TI - Discovery of novel small molecule mer kinase inhibitors for the treatment of pediatric acute lymphoblastic leukemia JO - ACS Med Chem Lett VL - 3 UR - https://doi.org/10.1021/ml200239k DO - 10.1021/ml200239k ID - Liu2012 ER - TY - JOUR AU - Pramanik, D. AU - Campbell, N. R. AU - Das, S. AU - Gupta, S. AU - Chenna, V. AU - Bisht, S. AU - Sysa-Shah, P. AU - Bedja, D. AU - Karikari, C. AU - Steenbergen, C. PY - 2012 DA - 2012// TI - A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy JO - Oncotarget VL - 3 UR - https://doi.org/10.18632/oncotarget.543 DO - 10.18632/oncotarget.543 ID - Pramanik2012 ER - TY - JOUR AU - Osman, A. M. AU - Al-Harthi, S. E. AU - Alarabi, O. M. AU - Elshal, M. F. AU - Ramadan, W. S. AU - Alaama, M. N. AU - Al-Kreathy, H. M. AU - Damanhouri, Z. A. AU - Osman, O. H. PY - 2013 DA - 2013// TI - Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals JO - Cancer Cell Int VL - 13 UR - https://doi.org/10.1186/1475-2867-13-52 DO - 10.1186/1475-2867-13-52 ID - Osman2013 ER - TY - JOUR AU - Osman, A. M. AU - Bayoumi, H. M. AU - Al-Harthi, S. E. AU - Damanhouri, Z. A. AU - Elshal, M. F. PY - 2012 DA - 2012// TI - Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line JO - Cancer Cell Int VL - 12 UR - https://doi.org/10.1186/1475-2867-12-47 DO - 10.1186/1475-2867-12-47 ID - Osman2012 ER - TY - JOUR AU - Lerma-Diaz, J. M. AU - Hernandez-Flores, G. AU - Dominguez-Rodriguez, J. R. AU - Ortiz-Lazareno, P. C. AU - Gomez-Contreras, P. AU - Cervantes-Munguia, R. AU - Scott-Algara, D. AU - Aguilar-Lemarroy, A. AU - Jave-Suarez, L. F. AU - Bravo-Cuellar, A. PY - 2006 DA - 2006// TI - In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IkappaBalpha phosphorylation JO - Immunol Lett VL - 103 UR - https://doi.org/10.1016/j.imlet.2005.10.019 DO - 10.1016/j.imlet.2005.10.019 ID - Lerma-Diaz2006 ER - TY - JOUR AU - Harati, K. AU - Chromik, A. M. AU - Bulut, D. AU - Goertz, O. AU - Hahn, S. AU - Hirsch, T. AU - Klein-Hitpass, L. AU - Lehnhardt, M. AU - Uhl, W. AU - Daigeler, A. PY - 2012 DA - 2012// TI - TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells JO - Anticancer Res VL - 32 ID - Harati2012 ER - TY - JOUR AU - Du, B. Y. AU - Song, W. AU - Bai, L. AU - Shen, Y. AU - Miao, S. Y. AU - Wang, L. F. PY - 2012 DA - 2012// TI - Synergistic effects of combination treatment with bortezomib and doxorubicin in human neuroblastoma cell lines JO - Chemotherapy VL - 58 UR - https://doi.org/10.1159/000335603 DO - 10.1159/000335603 ID - Du2012 ER - TY - JOUR AU - Cuellar, A. B. AU - Algara, D. S. AU - Metzger, G. AU - Orbach-Arbouys, S. PY - 1987 DA - 1987// TI - Enhanced activity of mouse peritoneal cells after aclacinomycin administration JO - Cancer Res VL - 47 ID - Cuellar1987 ER - TY - JOUR AU - Liu, J. AU - Zheng, H. AU - Tang, M. AU - Ryu, Y. C. AU - Wang, X. PY - 2008 DA - 2008// TI - A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome JO - Am J Physiol Heart Circ Physiol VL - 295 UR - https://doi.org/10.1152/ajpheart.01052.2008 DO - 10.1152/ajpheart.01052.2008 ID - Liu2008 ER - TY - JOUR AU - DiDonato, J. A. AU - Mercurio, F. AU - Karin, M. PY - 2012 DA - 2012// TI - NF-kappaB and the link between inflammation and cancer JO - Immunol Rev VL - 246 UR - https://doi.org/10.1111/j.1600-065X.2012.01099.x DO - 10.1111/j.1600-065X.2012.01099.x ID - DiDonato2012 ER - TY - JOUR AU - Mantovani, A. PY - 2010 DA - 2010// TI - Molecular pathways linking inflammation and cancer JO - Curr Mol Med VL - 10 UR - https://doi.org/10.2174/156652410791316968 DO - 10.2174/156652410791316968 ID - Mantovani2010 ER - TY - JOUR AU - Park, H. S. AU - Jun do, Y. AU - Han, C. R. AU - Woo, H. J. AU - Kim, Y. H. PY - 2011 DA - 2011// TI - Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells JO - Biochem Pharmacol VL - 82 UR - https://doi.org/10.1016/j.bcp.2011.07.085 DO - 10.1016/j.bcp.2011.07.085 ID - Park2011 ER - TY - JOUR AU - Chen, D. AU - Dou, Q. P. PY - 2010 DA - 2010// TI - The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention JO - Curr Protein Pept Sci VL - 11 UR - https://doi.org/10.2174/138920310791824057 DO - 10.2174/138920310791824057 ID - Chen2010 ER - TY - JOUR AU - Fournier, M. J. AU - Gareau, C. AU - Mazroui, R. PY - 2010 DA - 2010// TI - The chemotherapeutic agent bortezomib induces the formation of stress granules JO - Cancer Cell Int VL - 10 UR - https://doi.org/10.1186/1475-2867-10-12 DO - 10.1186/1475-2867-10-12 ID - Fournier2010 ER - TY - JOUR AU - Ortiz-Lazareno, P. C. AU - Hernandez-Flores, G. AU - Dominguez-Rodriguez, J. R. AU - Lerma-Diaz, J. M. AU - Jave-Suarez, L. F. AU - Aguilar-Lemarroy, A. AU - Gomez-Contreras, P. C. AU - Scott-Algara, D. AU - Bravo-Cuellar, A. PY - 2008 DA - 2008// TI - MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1 JO - Immunology VL - 124 UR - https://doi.org/10.1111/j.1365-2567.2008.02806.x DO - 10.1111/j.1365-2567.2008.02806.x ID - Ortiz-Lazareno2008 ER - TY - JOUR AU - Montagut, C. AU - Tusquets, I. AU - Ferrer, B. AU - Corominas, J. M. AU - Bellosillo, B. AU - Campas, C. AU - Suarez, M. AU - Fabregat, X. AU - Campo, E. AU - Gascon, P. PY - 2006 DA - 2006// TI - Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients JO - Endocr Relat Cancer VL - 13 UR - https://doi.org/10.1677/erc.1.01171 DO - 10.1677/erc.1.01171 ID - Montagut2006 ER - TY - JOUR AU - Izzo, J. G. AU - Malhotra, U. AU - Wu, T. T. AU - Ensor, J. AU - Luthra, R. AU - Lee, J. H. AU - Swisher, S. G. AU - Liao, Z. AU - Chao, K. S. AU - Hittelman, W. N. PY - 2006 DA - 2006// TI - Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.8810 DO - 10.1200/JCO.2005.03.8810 ID - Izzo2006 ER - TY - JOUR AU - Aranovich, A. AU - Liu, Q. AU - Collins, T. AU - Geng, F. AU - Dixit, S. AU - Leber, B. AU - Andrews, D. W. PY - 2012 DA - 2012// TI - Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells JO - Mol Cell VL - 45 UR - https://doi.org/10.1016/j.molcel.2012.01.030 DO - 10.1016/j.molcel.2012.01.030 ID - Aranovich2012 ER - TY - JOUR AU - Oiso, S. AU - Ikeda, R. AU - Nakamura, K. AU - Takeda, Y. AU - Akiyama, S. AU - Kariyazono, H. PY - 2012 DA - 2012// TI - Involvement of NF-kappaB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells JO - Oncol Rep VL - 28 ID - Oiso2012 ER - TY - JOUR AU - Reed, J. C. PY - 2008 DA - 2008// TI - Bcl-2-family proteins and hematologic malignancies: history and future prospects JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-09-078162 DO - 10.1182/blood-2007-09-078162 ID - Reed2008 ER - TY - JOUR AU - Bao, L. AU - Haque, A. AU - Jackson, K. AU - Hazari, S. AU - Moroz, K. AU - Jetly, R. AU - Dash, S. PY - 2011 DA - 2011// TI - Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model JO - Am J Pathol VL - 178 UR - https://doi.org/10.1016/j.ajpath.2010.10.029 DO - 10.1016/j.ajpath.2010.10.029 ID - Bao2011 ER - TY - JOUR AU - Naci, D. AU - El Azreq, M. A. AU - Chetoui, N. AU - Lauden, L. AU - Sigaux, F. AU - Charron, D. AU - Al-Daccak, R. AU - Aoudjit, F. PY - 2012 DA - 2012// TI - alpha2beta1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK) JO - J Biol Chem VL - 287 UR - https://doi.org/10.1074/jbc.M112.349365 DO - 10.1074/jbc.M112.349365 ID - Naci2012 ER - TY - JOUR AU - Steppan, I. AU - Reimer, D. AU - Sevelda, U. AU - Ulmer, H. AU - Marth, C. AU - Zeimet, A. G. PY - 2009 DA - 2009// TI - Treatment of recurrent platinum-resistant ovarian cancer with pegylated liposomal doxorubicin–an evaluation of the therapeutic index with special emphasis on cardiac toxicity JO - Chemotherapy VL - 55 UR - https://doi.org/10.1159/000262452 DO - 10.1159/000262452 ID - Steppan2009 ER - TY - JOUR AU - Gewirtz, D. A. AU - Holt, S. E. AU - Elmore, L. W. PY - 2008 DA - 2008// TI - Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation JO - Biochem Pharmacol VL - 76 UR - https://doi.org/10.1016/j.bcp.2008.06.024 DO - 10.1016/j.bcp.2008.06.024 ID - Gewirtz2008 ER - TY - JOUR AU - Tsirpanlis, G. PY - 2009 DA - 2009// TI - Cellular senescence and inflammation: a noteworthy link JO - Blood Purif VL - 28 UR - https://doi.org/10.1159/000210032 DO - 10.1159/000210032 ID - Tsirpanlis2009 ER - TY - JOUR AU - Ewald, J. A. AU - Desotelle, J. A. AU - Wilding, G. AU - Jarrard, D. F. PY - 2010 DA - 2010// TI - Therapy-induced senescence in cancer JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq364 DO - 10.1093/jnci/djq364 ID - Ewald2010 ER - TY - JOUR AU - Saretzki, G. PY - 2010 DA - 2010// TI - Cellular senescence in the development and treatment of cancer JO - Curr Pharm Des VL - 16 UR - https://doi.org/10.2174/138161210789941874 DO - 10.2174/138161210789941874 ID - Saretzki2010 ER - TY - JOUR AU - Leontieva, O. V. AU - Natarajan, V. AU - Demidenko, Z. N. AU - Burdelya, L. G. AU - Gudkov, A. V. AU - Blagosklonny, M. V. PY - 2012 DA - 2012// TI - Hypoxia suppresses conversion from proliferative arrest to cellular senescence JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1205690109 DO - 10.1073/pnas.1205690109 ID - Leontieva2012 ER - TY - JOUR AU - Cavaliere, V. AU - Papademetrio, D. L. AU - Lorenzetti, M. AU - Valva, P. AU - Preciado, M. V. AU - Gargallo, P. AU - Larripa, I. AU - Monreal, M. B. AU - Pardo, M. L. AU - Hajos, S. E. PY - 2009 DA - 2009// TI - Caffeic acid phenylethyl ester and MG-132 have apoptotic and antiproliferative effects on leukemic cells but not on normal mononuclear cells JO - Transl Oncol VL - 2 UR - https://doi.org/10.1593/tlo.08202 DO - 10.1593/tlo.08202 ID - Cavaliere2009 ER - TY - JOUR AU - Naujokat, C. AU - Sezer, O. AU - Zinke, H. AU - Leclere, A. AU - Hauptmann, S. AU - Possinger, K. PY - 2000 DA - 2000// TI - Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells JO - Eur J Haematol VL - 65 UR - https://doi.org/10.1034/j.1600-0609.2000.065004221.x DO - 10.1034/j.1600-0609.2000.065004221.x ID - Naujokat2000 ER - TY - JOUR AU - Goldberg, A. L. PY - 2007 DA - 2007// TI - Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy JO - Biochem Soc Trans VL - 35 UR - https://doi.org/10.1042/BST0350012 DO - 10.1042/BST0350012 ID - Goldberg2007 ER - TY - JOUR AU - Chen, D. AU - Frezza, M. AU - Schmitt, S. AU - Kanwar, J. AU - Dou, Q. P. PY - 2011 DA - 2011// TI - Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives JO - Curr Cancer Drug Targets VL - 11 UR - https://doi.org/10.2174/156800911794519752 DO - 10.2174/156800911794519752 ID - Chen2011 ER - TY - JOUR AU - Chauhan, D. AU - Anderson, K. C. PY - 2011 DA - 2011// TI - Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Cas JO - BMC Biol VL - 9 UR - https://doi.org/10.1186/1741-7007-9-72 DO - 10.1186/1741-7007-9-72 ID - Chauhan2011 ER - TY - JOUR AU - Yang, F. AU - Teves, S. S. AU - Kemp, C. J. AU - Henikoff, S. PY - 2013 DA - 2013// TI - Doxorubicin, DNA torsion, and chromatin dynamics JO - Biochim Biophys Acta VL - 1845 ID - Yang2013 ER - TY - JOUR AU - Wang, S. AU - Konorev, E. A. AU - Kotamraju, S. AU - Joseph, J. AU - Kalivendi, S. AU - Kalyanaraman, B. PY - 2004 DA - 2004// TI - Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M400944200 DO - 10.1074/jbc.M400944200 ID - Wang2004 ER - TY - JOUR AU - Suzuki, F. AU - Hashimoto, K. AU - Kikuchi, H. AU - Nishikawa, H. AU - Matsumoto, H. AU - Shimada, J. AU - Kawase, M. AU - Sunaga, K. AU - Tsuda, T. AU - Satoh, K. PY - 2005 DA - 2005// TI - Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin JO - Anticancer Res VL - 25 ID - Suzuki2005 ER - TY - JOUR AU - Lipshultz, S. E. AU - Miller, T. L. AU - Scully, R. E. AU - Lipsitz, S. R. AU - Rifai, N. AU - Silverman, L. B. AU - Colan, S. D. AU - Neuberg, D. S. AU - Dahlberg, S. E. AU - Henkel, J. M. PY - 2012 DA - 2012// TI - Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2010.30.3404 DO - 10.1200/JCO.2010.30.3404 ID - Lipshultz2012 ER - TY - JOUR AU - Pang, B. AU - Qiao, X. AU - Janssen, L. AU - Velds, A. AU - Groothuis, T. AU - Kerkhoven, R. AU - Nieuwland, M. AU - Ovaa, H. AU - Rottenberg, S. AU - van Tellingen, O. PY - 1908 DA - 1908// TI - Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin JO - Nat Commun VL - 2013 ID - Pang1908 ER - TY - JOUR AU - Denard, B. AU - Lee, C. AU - Ye, J. PY - 2012 DA - 2012// TI - Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 JO - eLife VL - 1 UR - https://doi.org/10.7554/eLife.00090 DO - 10.7554/eLife.00090 ID - Denard2012 ER - TY - JOUR AU - Vantus, T. AU - Vertommen, D. AU - Saelens, X. AU - Rykx, A. AU - De Kimpe, L. AU - Vancauwenbergh, S. AU - Mikhalap, S. AU - Waelkens, E. AU - Keri, G. AU - Seufferlein, T. PY - 2004 DA - 2004// TI - Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing JO - Cell Signal VL - 16 UR - https://doi.org/10.1016/j.cellsig.2003.11.009 DO - 10.1016/j.cellsig.2003.11.009 ID - Vantus2004 ER - TY - JOUR AU - Tao, Z. AU - Goodisman, J. AU - Penefsky, H. S. AU - Souid, A. K. PY - 2007 DA - 2007// TI - Caspase activation by anticancer drugs: the caspase storm JO - Mol Pharm VL - 4 UR - https://doi.org/10.1021/mp070002r DO - 10.1021/mp070002r ID - Tao2007 ER - TY - JOUR AU - Han, Y. H. AU - Moon, H. J. AU - You, B. R. AU - Park, W. H. PY - 2009 DA - 2009// TI - The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH JO - Oncol Rep VL - 22 ID - Han2009 ER - TY - JOUR AU - Van Geelen, C. M. AU - Pennarun, B. AU - Ek, W. B. AU - Le, P. T. AU - Spierings, D. C. AU - De Vries, E. G. AU - De Jong, S. PY - 2010 DA - 2010// TI - Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines JO - Int J Oncol VL - 37 ID - Van Geelen2010 ER - TY - JOUR AU - Gamen, S. AU - Anel, A. AU - Perez-Galan, P. AU - Lasierra, P. AU - Johnson, D. AU - Pineiro, A. AU - Naval, J. PY - 2000 DA - 2000// TI - Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells JO - Exp Cell Res VL - 258 UR - https://doi.org/10.1006/excr.2000.4924 DO - 10.1006/excr.2000.4924 ID - Gamen2000 ER - TY - JOUR AU - Bagriacik, E. U. AU - Uslu, K. AU - Yurtcu, E. AU - Stefek, M. AU - Karasu, C. PY - 2007 DA - 2007// TI - Stobadine inhibits doxorubicin-induced apoptosis through a caspase-9 dependent pathway in P815 mastocytoma cells JO - Cell Biol Int VL - 31 UR - https://doi.org/10.1016/j.cellbi.2007.03.008 DO - 10.1016/j.cellbi.2007.03.008 ID - Bagriacik2007 ER - TY - JOUR AU - Fulda, S. AU - Galluzzi, L. AU - Kroemer, G. PY - 2010 DA - 2010// TI - Targeting mitochondria for cancer therapy JO - Nat Rev Drug Discov VL - 9 UR - https://doi.org/10.1038/nrd3137 DO - 10.1038/nrd3137 ID - Fulda2010 ER - TY - JOUR AU - Holmuhamedov, E. AU - Lewis, L. AU - Bienengraeber, M. AU - Holmuhamedova, M. AU - Jahangir, A. AU - Terzic, A. PY - 2002 DA - 2002// TI - Suppression of human tumor cell proliferation through mitochondrial targeting JO - FASEB J VL - 16 UR - https://doi.org/10.1096/fj.01-0996com DO - 10.1096/fj.01-0996com ID - Holmuhamedov2002 ER - TY - JOUR AU - Bonnet, S. AU - Archer, S. L. AU - Allalunis-Turner, J. AU - Haromy, A. AU - Beaulieu, C. AU - Thompson, R. AU - Lee, C. T. AU - Lopaschuk, G. D. AU - Puttagunta, L. AU - Bonnet, S. PY - 2007 DA - 2007// TI - A mitochondria-K + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth JO - Cancer Cell VL - 11 UR - https://doi.org/10.1016/j.ccr.2006.10.020 DO - 10.1016/j.ccr.2006.10.020 ID - Bonnet2007 ER - TY - JOUR AU - Heerdt, B. G. AU - Houston, M. A. AU - Augenlicht, L. H. PY - 2005 DA - 2005// TI - The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-2444 DO - 10.1158/0008-5472.CAN-05-2444 ID - Heerdt2005 ER - TY - JOUR AU - Gogvadze, V. AU - Orrenius, S. AU - Zhivotovsky, B. PY - 2008 DA - 2008// TI - Mitochondria in cancer cells: what is so special about them? JO - Trends Cell Biol VL - 18 UR - https://doi.org/10.1016/j.tcb.2008.01.006 DO - 10.1016/j.tcb.2008.01.006 ID - Gogvadze2008 ER - TY - JOUR AU - Takahashi, A. AU - Ohtani, N. AU - Hara, E. PY - 2007 DA - 2007// TI - Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control JO - Cell Div VL - 2 UR - https://doi.org/10.1186/1747-1028-2-10 DO - 10.1186/1747-1028-2-10 ID - Takahashi2007 ER - TY - JOUR AU - Grimes, A. AU - Chandra, S. B. PY - 2009 DA - 2009// TI - Significance of cellular senescence in aging and cancer JO - Cancer Res Treat VL - 41 UR - https://doi.org/10.4143/crt.2009.41.4.187 DO - 10.4143/crt.2009.41.4.187 ID - Grimes2009 ER - TY - JOUR AU - Coppe, J. P. AU - Desprez, P. Y. AU - Krtolica, A. AU - Campisi, J. PY - 2010 DA - 2010// TI - The senescence-associated secretory phenotype: the dark side of tumor suppression JO - Annu Rev Pathol VL - 5 UR - https://doi.org/10.1146/annurev-pathol-121808-102144 DO - 10.1146/annurev-pathol-121808-102144 ID - Coppe2010 ER - TY - JOUR AU - Krtolica, A. AU - Parrinello, S. AU - Lockett, S. AU - Desprez, P. Y. AU - Campisi, J. PY - 2001 DA - 2001// TI - Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.211053698 DO - 10.1073/pnas.211053698 ID - Krtolica2001 ER - TY - JOUR AU - Rodier, F. AU - Campisi, J. PY - 2011 DA - 2011// TI - Four faces of cellular senescence JO - J Cell Biol VL - 192 UR - https://doi.org/10.1083/jcb.201009094 DO - 10.1083/jcb.201009094 ID - Rodier2011 ER - TY - JOUR AU - Hernandez-Flores, G. AU - Ortiz-Lazareno, P. C. AU - Lerma-Diaz, J. M. AU - Dominguez-Rodriguez, J. R. AU - Jave-Suarez, L. F. AU - Aguilar-Lemarroy Adel, C. AU - de Celis-Carrillo, R. AU - del Toro-Arreola, S. AU - Castellanos-Esparza, Y. C. AU - Bravo-Cuellar, A. PY - 2011 DA - 2011// TI - Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-483 DO - 10.1186/1471-2407-11-483 ID - Hernandez-Flores2011 ER - TY - JOUR AU - Ohtani, N. AU - Takahashi, A. AU - Mann, D. J. AU - Hara, E. PY - 2012 DA - 2012// TI - Cellular senescence: a double-edged sword in the fight against cancer JO - Exp Dermatol VL - 21 UR - https://doi.org/10.1111/j.1600-0625.2012.01493.x DO - 10.1111/j.1600-0625.2012.01493.x ID - Ohtani2012 ER - TY - JOUR AU - Coppe, J. P. AU - Patil, C. K. AU - Rodier, F. AU - Sun, Y. AU - Munoz, D. P. AU - Goldstein, J. AU - Nelson, P. S. AU - Desprez, P. Y. AU - Campisi, J. PY - 2008 DA - 2008// TI - Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor JO - PLoS Biol VL - 6 UR - https://doi.org/10.1371/journal.pbio.0060301 DO - 10.1371/journal.pbio.0060301 ID - Coppe2008 ER - TY - JOUR AU - Wang, Y. W. AU - Wang, S. J. AU - Zhou, Y. N. AU - Pan, S. H. AU - Sun, B. PY - 2012 DA - 2012// TI - Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in pancreatic cancer both in vitro and in vivo JO - J Cancer Res Clin Oncol VL - 138 UR - https://doi.org/10.1007/s00432-012-1152-z DO - 10.1007/s00432-012-1152-z ID - Wang2012 ER - TY - JOUR AU - Sun, J. G. AU - Chen, C. Y. AU - Luo, K. W. AU - Yeung, C. L. AU - Tsang, T. Y. AU - Huang, Z. Z. AU - Wu, P. AU - Fung, K. P. AU - Kwok, T. T. AU - Liu, F. Y. PY - 2011 DA - 2011// TI - 3,5-Dimethyl-H-furo[3,2-g]chromen-7-one as a potential anticancer drug by inducing p53-dependent apoptosis in human hepatoma HepG2 cells JO - Chemotherapy VL - 57 UR - https://doi.org/10.1159/000326915 DO - 10.1159/000326915 ID - Sun2011 ER - TY - JOUR AU - Hussain, A. R. AU - Ahmed, S. O. AU - Ahmed, M. AU - Khan, O. S. AU - Al Abdulmohsen, S. AU - Platanias, L. C. AU - Al-Kuraya, K. S. AU - Uddin, S. PY - 2012 DA - 2012// TI - Cross-talk between NFkB and the PI3-Kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0039945 DO - 10.1371/journal.pone.0039945 ID - Hussain2012 ER - TY - JOUR AU - Yan, M. AU - Xu, Q. AU - Zhang, P. AU - Zhou, X. J. AU - Zhang, Z. Y. AU - Chen, W. T. PY - 2010 DA - 2010// TI - Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-437 DO - 10.1186/1471-2407-10-437 ID - Yan2010 ER - TY - JOUR AU - Sha, M. AU - Ye, J. AU - Zhang, L. X. AU - Luan, Z. Y. AU - Chen, Y. B. PY - 2013 DA - 2013// TI - Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-kappaB activity JO - Cancer Cell Int VL - 13 UR - https://doi.org/10.1186/1475-2867-13-50 DO - 10.1186/1475-2867-13-50 ID - Sha2013 ER - TY - JOUR AU - La Ferla-Bruhl, K. AU - Westhoff, M. A. AU - Karl, S. AU - Kasperczyk, H. AU - Zwacka, R. M. AU - Debatin, K. M. AU - Fulda, S. PY - 2007 DA - 2007// TI - NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1209841 DO - 10.1038/sj.onc.1209841 ID - La Ferla-Bruhl2007 ER - TY - JOUR AU - Zanotto-Filho, A. AU - Braganhol, E. AU - Battastini, A. M. AU - Moreira, J. C. PY - 2012 DA - 2012// TI - Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling JO - Invest New Drugs VL - 30 UR - https://doi.org/10.1007/s10637-012-9804-z DO - 10.1007/s10637-012-9804-z ID - Zanotto-Filho2012 ER - TY - JOUR AU - Zanotto-Filho, A. AU - Delgado-Canedo, A. AU - Schroder, R. AU - Becker, M. AU - Klamt, F. AU - Moreira, J. C. PY - 2010 DA - 2010// TI - The pharmacological NFkappaB inhibitors BAY117082 and MG132 induce cell arrest and apoptosis in leukemia cells through ROS-mitochondria pathway activation JO - Cancer Lett VL - 288 UR - https://doi.org/10.1016/j.canlet.2009.06.038 DO - 10.1016/j.canlet.2009.06.038 ID - Zanotto-Filho2010 ER - TY - JOUR AU - Sen, G. S. AU - Mohanty, S. AU - Hossain, D. M. AU - Bhattacharyya, S. AU - Banerjee, S. AU - Chakraborty, J. AU - Saha, S. AU - Ray, P. AU - Bhattacharjee, P. AU - Mandal, D. PY - 2011 DA - 2011// TI - Curcumin enhances the efficacy of chemotherapy by tailoring p65NFkappaB-p300 cross-talk in favor of p53-p300 in breast cancer JO - J Biol Chem VL - 286 UR - https://doi.org/10.1074/jbc.M111.262295 DO - 10.1074/jbc.M111.262295 ID - Sen2011 ER - TY - JOUR AU - Choi, C. H. AU - Xu, H. AU - Bark, H. AU - Lee, T. B. AU - Yun, J. AU - Kang, S. I. AU - Oh, Y. K. PY - 2007 DA - 2007// TI - Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines JO - Leuk Res VL - 31 UR - https://doi.org/10.1016/j.leukres.2006.11.006 DO - 10.1016/j.leukres.2006.11.006 ID - Choi2007 ER - TY - JOUR AU - Yeh, P. Y. AU - Chuang, S. E. AU - Yeh, K. H. AU - Song, Y. C. AU - Cheng, A. L. PY - 2003 DA - 2003// TI - Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells JO - Biochem Pharmacol VL - 66 UR - https://doi.org/10.1016/S0006-2952(03)00250-8 DO - 10.1016/S0006-2952(03)00250-8 ID - Yeh2003 ER - TY - JOUR AU - Zhang, W. AU - Ding, W. AU - Chen, Y. AU - Feng, M. AU - Ouyang, Y. AU - Yu, Y. AU - He, Z. PY - 2011 DA - 2011// TI - Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells JO - Acta Biochim Biophys Sin (Shanghai) VL - 43 UR - https://doi.org/10.1093/abbs/gmr050 DO - 10.1093/abbs/gmr050 ID - Zhang2011 ER - TY - JOUR AU - Wang, L. AU - Kang, F. AU - Li, J. AU - Zhang, J. AU - Shan, B. PY - 2013 DA - 2013// TI - Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line JO - Cancer Cell Int VL - 13 UR - https://doi.org/10.1186/1475-2867-13-14 DO - 10.1186/1475-2867-13-14 ID - Wang2013 ER - TY - JOUR AU - Chen, K. F. AU - Lin, J. P. AU - Shiau, C. W. AU - Tai, W. T. AU - Liu, C. Y. AU - Yu, H. C. AU - Chen, P. J. AU - Cheng, A. L. PY - 2012 DA - 2012// TI - Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells JO - Biochem Pharmacol VL - 84 UR - https://doi.org/10.1016/j.bcp.2012.04.023 DO - 10.1016/j.bcp.2012.04.023 ID - Chen2012 ER - TY - JOUR AU - Golbano, J. M. AU - Loppez-Aparicio, P. AU - Recio, M. N. AU - Perez-Albarsanz, M. A. PY - 2008 DA - 2008// TI - Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer cell line JO - Int J Oncol VL - 32 ID - Golbano2008 ER - TY - JOUR AU - Carbone, C. AU - Melisi, D. PY - 2012 DA - 2012// TI - NF-kappaB as a target for pancreatic cancer therapy JO - Expert Opin Ther Targets VL - 16 UR - https://doi.org/10.1517/14728222.2011.645806 DO - 10.1517/14728222.2011.645806 ID - Carbone2012 ER - TY - JOUR AU - Sethi, G. AU - Sung, B. AU - Aggarwal, B. B. PY - 2008 DA - 2008// TI - Nuclear factor-kappaB activation: from bench to bedside JO - Exp Biol Med (Maywood) VL - 233 UR - https://doi.org/10.3181/0707-MR-196 DO - 10.3181/0707-MR-196 ID - Sethi2008 ER - TY - JOUR AU - Suen, D. F. AU - Norris, K. L. AU - Youle, R. J. PY - 2008 DA - 2008// TI - Mitochondrial dynamics and apoptosis JO - Genes Dev VL - 22 UR - https://doi.org/10.1101/gad.1658508 DO - 10.1101/gad.1658508 ID - Suen2008 ER - TY - JOUR AU - Altieri, D. C. PY - 2003 DA - 2003// TI - Validating survivin as a cancer therapeutic target JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc968 DO - 10.1038/nrc968 ID - Altieri2003 ER - TY - JOUR AU - Kannaiyan, R. AU - Hay, H. S. AU - Rajendran, P. AU - Li, F. AU - Shanmugam, M. K. AU - Vali, S. AU - Abbasi, T. AU - Kapoor, S. AU - Sharma, A. AU - Kumar, A. P. PY - 2011 DA - 2011// TI - Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-kappaB and STAT3 regulated gene products in multiple myeloma cells JO - Br J Pharmacol VL - 164 UR - https://doi.org/10.1111/j.1476-5381.2011.01449.x DO - 10.1111/j.1476-5381.2011.01449.x ID - Kannaiyan2011 ER -